Furthermore, the significant reduction of VWF expression in MDA-MB-231 and MCF-7 cell lines suggested the potential of miRNAs as therapeutic agents to inhibit VWF-mediated pathways in BC (Figs. 7D, 7E). This evidence concerns the gene VWF and breast cancer.